Cargando…
Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes
BACKGROUND: Whether there are differences in the risk profile and treatment effect in patients recruited in a low recruitment center (LRC) versus patients recruited in a high recruitment center (HRC) in a randomized multicenter trial remains unknown. METHODS AND RESULTS: This study included 4018 pat...
Autores principales: | Ndrepepa, Gjin, Neumann, Franz‐Josef, Menichelli, Maurizio, Bernlochner, Isabell, Richardt, Gert, Wöhrle, Jochen, Witzenbichler, Bernhard, Mayer, Katharina, Cassese, Salvatore, Gewalt, Senta, Xhepa, Erion, Kufner, Sebastian, Sager, Hendrik B., Joner, Michael, Ibrahim, Tareq, Laugwitz, Karl‐Ludwig, Schunkert, Heribert, Schüpke, Stefanie, Kastrati, Adnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751942/ https://www.ncbi.nlm.nih.gov/pubmed/34779234 http://dx.doi.org/10.1161/JAHA.121.021418 |
Ejemplares similares
-
Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial
por: Gewalt, Senta, et al.
Publicado: (2022) -
Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial
por: Behnes, Michael, et al.
Publicado: (2022) -
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
por: Koch, Tobias, et al.
Publicado: (2023) -
Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes ‐ A Post‐hoc Analysis of the ISAR‐REACT 5 Trial
por: Lahu, Shqipdona, et al.
Publicado: (2022) -
Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes
por: Ndrepepa, Gjin, et al.
Publicado: (2021)